Neil Bhowmick, Chief Scientific Officer at Kairos Pharma, explores the biology of cancer drug resistance and the opportunities to overcome it. Despite extraordinary advancements in how we treat cancer, ranging from cytotoxic chemotherapy to precision immunotherapies, one fundamental barrier consistently impedes… Read More
The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW’s Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news. Last week, a UK group accelerated efforts to develop a vaccine for Ebolavirus. Elsewhere,… Read More
News round-up for 25–29 May by Bruno Quinney, Content Team at DDW. This week, a UK group has accelerated efforts to develop a vaccine for Ebolavirus. Elsewhere, significant findings in colorectal and brain cancer could shape future cancer treatments. The top stories: UK group steps… Read More
Brain cancer could be treated more easily using stem cells from the lining of the mouth, new research suggests. Scientists at the University of Reading found that when stem cells from the mouth were transplanted into mouse brain tissue, they slowed cancer growth and reduced the size… Read More
James L Sherley, MD, PhD, explores how a new method for quantifying stem cells in mesenchymal tissue samples can lead to better drug development for stem cell therapies. Mesenchymal tissue cell samples are considered incredibly promising for the development of new stem cell therapies. These samples can be based on bone… Read More
Stem cell technologies company Axol Bioscience has acquired the ophthalmology business of Newcells Biotech. The acquisition of Newcells’ ophthalmology business includes its specialist team, facilities and intellectual property related to supply of proprietary iPSC-derived products and ophthalmology research services to biopharma, biotechnology and CRO customers across Europe and… Read More
Kidswell Bio and Treehill Partners have announced the creation of a new US based regenerative medicine company, Kidswell USA. The companies say Kidswell USA will be formed for the purpose of accelerating the development of Kidswell’s cell therapy pipeline, currently targeting cerebral palsy (CP) as a lead… Read More
This is the latest episode of the free DDW Narrated Podcast, called “How new scientific approaches are accelerating R&D”. The episode covers two articles written for DDW Volume 25, Issue 1, Winter 2023/24. The first article is called ‘Accelerating recombinant protein vaccine discovery’. In the… Read More
This is the latest episode of the free DDW narrated podcast, titled “Overcoming barriers to patient access”, which covers two articles written for DDW Volume 25 – Issue 1, Winter 2023/24. They are called: “Scaling up: The need for human cells to give better access to cell therapies” and… Read More
New research led by Californian institute USC Stem Cell has broken new ground by building mouse and human synthetic kidneys. In a new paper published in Cell Stem Cell, the scientists describe generating more mature and complex lab-grown kidney structures, or organoids, than… Read More
Cancer is no longer seen as a simple disease of unchecked cell growth, but as a complex, adaptive ecosystem shaped by genetic mutations, immune evasion, and transcriptional plasticity that allow tumours to survive and evolve. Steve Pollard, CSO & Founder of Trogenix and Professor of Stem Cell and Cancer Biology,… Read More
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending granting conditional marketing authorisation for Zemcelpro (UM171 cell therapy). The positive opinion relates to the treatment of adults with haematological malignancies requiring an allogeneic haematopoietic stem… Read More
This is the latest episode of the free DDW narrated podcast, titled “Innovative uses for biomarkers in drug discovery”, which covers three articles written for DDW Volume 24 – Issue 4, Fall 2023. They are called: “Advances in neuroscience drug discovery”, “Putting human data at the centre of… Read More
This is the latest episode of the free DDW narrated podcast, titled “An overview on the impact of synthetic biology”, which covers two articles written for DDW Volume 24 – Issue 3, Summer 2023. They are called: “Synthetic biology: Impacting drug discovery” and “Synthetic biology: Innovating in drug… Read More
DDW Editor Reece Armstrong looks at how advances in stem cells, organoids and 3D cell cultures are affecting drug discovery and development. Stem cells, organoids and 3D cell cultures have emerged as promising tools that scientists can use to better understand disease and how drugs function within the human… Read More
This advertorial for Sampled appeared in DDW Volume 26 – Issue 2, Spring 2025 Read the digital issue Some technologies are always ‘on the horizon’, but induced pluripotent stem cells (iPSCs) have finally arrived. Researchers can transform iPSCs into virtually any cell type, making them invaluable for disease modelling,… Read More
